Abstract
Fibromyalgia (FM) is a syndrome characterized by widespread musculoskeletal pain, non-restorative sleep, fatigue, cognitive changes, and depressive and anxiety symptoms. There is a high prevalence of overweight in these patients, around 80%. Studies demonstrate common pathophysiological pathways between FM and obesity, such as dysfunctional eating behavior and altered dopaminergic neurotransmission. In this context, the contribution of non-pharmacological interventions, in order to rebalance the dopaminergic system, such as transcranial direct current stimulation (tDCS), are important.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
